What should be included in a petition to the USPTO Director?

A well-prepared petition to the USPTO Director should include several key elements: A clear statement of the relief requested The facts and circumstances supporting the petition The legal basis for the requested relief Any evidence supporting the petition The appropriate petition fee, if required It’s important to note that 37 CFR 1.4(c) requires a separate…

Read More

How should applicants update the USPTO about ongoing litigation during the reissue process?

Applicants have an ongoing duty to keep the USPTO informed about litigation involving the patent under reissue. The MPEP provides guidance on this matter: “The status of the litigation should be updated in the reissue application as soon as significant events happen in the litigation.” This means that applicants should: Promptly inform the USPTO of…

Read More

How does unity of invention practice differ between national applications under 35 U.S.C. 111(a) and national stage applications under 35 U.S.C. 371?

The unity of invention practice differs as follows: For national applications under 35 U.S.C. 111(a): These are subject to U.S. restriction practice under 37 CFR 1.141-1.146. For national stage applications under 35 U.S.C. 371: These are subject to unity of invention practice under 37 CFR 1.475 and 1.499. MPEP 1896 states: “U.S. national applications filed…

Read More

How does litigation or a PTAB trial affect the time extensions for reissue applications?

For reissue applications being examined during litigation or PTAB trials, or after such proceedings have been stayed or dismissed: Applicants are normally given 2 months to reply to Office actions This 2-month period can only be extended upon showing clear justification under 37 CFR 1.136(b) The provisions of 37 CFR 1.136(a) for automatic extensions are…

Read More

Can a reissue application be used to provoke an interference?

Yes, a reissue application can be used to provoke an interference under certain circumstances. According to the MPEP, In appropriate circumstances, a reissue application subject to pre-AIA 35 U.S.C. 102(g) (first to invent) may be placed into interference with a patent or pending application. However, there are specific conditions that must be met: The reissue…

Read More

What are the priority claim requirements for a national application under 35 U.S.C. 111(a) versus a national stage application under 35 U.S.C. 371?

The priority claim requirements differ as follows: For a national application under 35 U.S.C. 111(a): The claim for priority must be filed within the later of four months from the actual filing date or sixteen months from the prior foreign application filing date, as per 37 CFR 1.55(d). For a national stage application under 35…

Read More